Oncology

New blood test to diagnose ovarian cancer developed

Researchers have identified a network of circulating microRNAs - small, non-coding pieces of genetic material - that are associated with a risk of ovarian cancer and can be detected from blood samples. The team, from Brigham and Women's Hospital (BWH) and Dana-Farber Cancer Institute, US, said...

Pregnancy ‘does not pose breast cancer relapse risk’

Pregnancy does not incur a greater risk of relapse for survivors of breast cancer, according to a study by an international group of researchers. Published in the Journal of the National Cancer Institute, the study compared breast cancer survivors who became pregnant with those who did not become...

Study reveals clues to mechanisms of breast cancer

An international collaboration has identified 72 new genetic variants that contribute to the risk of developing breast cancer. Of these, the researchers revealed, 65 are common variants that predispose to breast cancer and a further seven predispose specifically to oestrogen-receptor negative...

Ovarian cancer ‘may begin in fallopian tubes’

The genomic roots of many ovarian cancer tumours may begin in the fallopian tubes, according to a new study. According to the researchers, this discovery can potentially provide insights into the origin of ovarian cancer and suggest new ways for prevention and intervention of the disease. They...

Cancer linked with breast implants ‘may be underreported’

A rare cancer developed by some patients with breast implants may be on the rise, but not all patients or doctors are aware of the risks of augmentation, according to new research. Scientists from Penn State College of Medicine explained that breast implant-associated anaplastic large cell lymphoma...

Machine learning can identify pre-breast cancer lesions

A machine learning tool has the ability to help identify which high-risk breast lesions are likely to become cancerous, according to a new study by Massachusetts General Hospital (MGH), US. Researchers said the technology has the potential to reduce unnecessary surgeries. High-risk breast lesions...

Safety of HPV vaccination in adult women investigated

Researchers at the Statens Serum Institut, in Denmark, have been investigating whether the human papillomavirus (HPV) vaccination is safe in adult women. In their study of more than three million Danish and Swedish women, they found that it was not linked with 44 serious chronic diseases. However,...

Higher lymphocyte infiltration predicts increased ovarian cancer survival rates

A new study from the Mayo Clinic and University of New South Wales Sydney has revealed how levels of immune response could be used to predict survival rates in patients with ovarian cancer. Published by the Ovarian Tumor Tissue Analysis Consortium in JAMA Oncology, the research examined levels of a...

October is Breast Cancer Awareness Month

October is Breast Cancer Awareness Month worldwide. It sees women joining forces to raise awareness of the disease, which is the most common cancer in the UK. Some one in eight women in the UK will develop breast cancer in their lifetime, and one person is diagnosed with the disease every ten...

Breast cancer death rates ‘fell 39% between 1989 and 2015’

Breast cancer death rates dropped 39 percent between 1989 and 2015, according to Breast Cancer Statistics, published in CA: A Cancer Journal for Clinicians. The findings also revealed that while black women continue to have higher breast cancer death rates than white women across the US, death...